Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1955 2
1958 1
1959 1
1960 1
1961 1
1962 1
1963 3
1972 1
1976 1
1977 2
1978 1
1980 1
1981 1
1986 1
1987 1
1989 3
1990 1
1991 1
1992 1
1994 3
1996 4
1997 10
1998 16
1999 13
2000 14
2001 6
2002 11
2003 9
2004 11
2005 11
2006 17
2007 5
2008 6
2009 5
2010 13
2011 12
2012 6
2013 12
2014 5
2015 6
2016 12
2017 9
2018 9
2019 15
2020 15
2021 10
2022 9
2023 16
2024 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

302 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial.
Zinman B, Aroda VR, Buse JB, Cariou B, Harris SB, Hoff ST, Pedersen KB, Tarp-Johansen MJ, Araki E; PIONEER 8 Investigators. Zinman B, et al. Among authors: harris sb. Diabetes Care. 2019 Dec;42(12):2262-2271. doi: 10.2337/dc19-0898. Epub 2019 Sep 17. Diabetes Care. 2019. PMID: 31530667 Free PMC article. Clinical Trial.
Surveillance du glucose en continu.
Harris SB, Bari B, Gilbert J. Harris SB, et al. CMAJ. 2024 Mar 10;196(9):E325-E326. doi: 10.1503/cmaj.230572-f. CMAJ. 2024. PMID: 38467414 Free PMC article. French. No abstract available.
Continuous glucose monitoring.
Harris SB, Bari B, Gilbert J. Harris SB, et al. CMAJ. 2023 Nov 14;195(44):E1509. doi: 10.1503/cmaj.230572. CMAJ. 2023. PMID: 37963623 Free PMC article. No abstract available.
Multitherapy for diabetes.
Harris SB. Harris SB. CMAJ. 2006 Nov 7;175(10):1247-8. doi: 10.1503/cmaj.1060002. CMAJ. 2006. PMID: 17098959 Free PMC article. No abstract available.
Diabetes remission and relapse following an intensive metabolic intervention combining insulin glargine/lixisenatide, metformin and lifestyle approaches: Results of a randomised controlled trial.
McInnes N, Hall S, Lochnan HA, Harris SB, Punthakee Z, Sigal RJ, Hramiak I, Azharuddin M, Liutkus JF, Yale JF, Sultan F, Smith A, Otto RE, Sherifali D, Liu YY, Gerstein HC; REMIT-iGlarLixi Collaborative Group. McInnes N, et al. Among authors: harris sb. Diabetes Obes Metab. 2023 Nov;25(11):3347-3355. doi: 10.1111/dom.15234. Epub 2023 Aug 14. Diabetes Obes Metab. 2023. PMID: 37580972 Clinical Trial.
Recommendation to change the peer review process.
Wise LD, Harris SB, Webster WS, DeSesso JM. Wise LD, et al. Among authors: harris sb. Birth Defects Res. 2023 Dec 1;115(20):1881-1882. doi: 10.1002/bdr2.2255. Epub 2023 Oct 5. Birth Defects Res. 2023. PMID: 37799018 No abstract available.
302 results